Home / News / India /  India’s framework has a specific provision for granting EUA: Official on Covid vaccines

India’s regulatory framework has a specific provision for grant of emergency use authorisation, said Rajesh Bhushan, Secretary, Union Health Ministry said on Covid-19 vaccines.

Bhushan's statement on Tuesday comes at a time when after Pfizer and Serum Institute, Hyderabad-based pharmaceutical firm Bharat Biotech had on Monday applied to the central drug regulator seeking emergency use authorisation for its COVID-19 vaccine Covaxin.

Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

The Hyderabad-based firm is conducting phase-3 clinical trial of its vaccine in around 25 places, including Delhi, Mumbai, Patna and Lucknow.

The firm, while applying for the phase-3 trial, had stated that the vaccine was well-tolerated in all dose groups and no serious adverse events have been reported.

Bhushan also said that Drugs Controller General of India could grant a license to some developers of Covid-19 vaccines in the next few weeks.

Six vaccines, including AstraZeneca's Covidshield and Bharat Biotech's Covaxin, are in trial stages, Bhushan said at a press conference.

Current cold chain capable of storing first lot of 3 crore Covid-19 vaccines for healthcare, frontline workers, the official further said.

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Recommended For You

Edit Profile
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout